跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,171 条关于
“ReWalk 6.0”
全部
15,171
临床试验
13,922
药物
250
机构
19
资讯
980
去年
FDA Grants 510(k) Clearance for ReWalk 7 Exoskeleton for Spinal Cord Injury Patients
去年
Lifeward Partners with CorLife to Expand Workers' Compensation Access to ReWalk Exoskeleton
8个月前
Oramed and Lifeward Announce Strategic Merger Creating Diversified Biomedical Platform
去年
Johnson & Johnson MedTech Temporarily Pauses U.S. Varipulse Cases
去年
Protalix's PRX-115 Demonstrates Promising Results in Phase I Gout Trial
去年
Phase 3 Trials Launched to Evaluate Datopotamab Deruxtecan Combinations in Advanced NSCLC
4个月前
NICE Expands Access to AstraZeneca's Lokelma as Hyperkalemia Treatment Threshold Lowered
去年
Roche's Vabysmo Prefilled Syringe Approved in EU for Retinal Conditions
去年
Daiichi Sankyo and AstraZeneca Initiate Three Phase 3 Trials of Datopotamab Deruxtecan Combinations in NSCLC
去年
Immatics' IMA203 Demonstrates Promising Efficacy and Safety in Melanoma Phase 1 Trial
第 1 页,共 98 页
上一页
下一页